Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication

NCT03650543 is registered in ClinicalTrials.gov with Javeriana University as lead sponsor.

NCT NCT03650543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03650543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication
Lead sponsor
Javeriana University
Phase
Phase 4
Overall status
Completed
Start date
September 10, 2012
Completion date
August 8, 2015
Enrollment
133 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cyp2c19 polymorphism, h.pylori infection, therapy